[go: up one dir, main page]

ES2010538A6 - Procedimiento para la preparacion de un gen sintetico. - Google Patents

Procedimiento para la preparacion de un gen sintetico.

Info

Publication number
ES2010538A6
ES2010538A6 ES8801342A ES8801342A ES2010538A6 ES 2010538 A6 ES2010538 A6 ES 2010538A6 ES 8801342 A ES8801342 A ES 8801342A ES 8801342 A ES8801342 A ES 8801342A ES 2010538 A6 ES2010538 A6 ES 2010538A6
Authority
ES
Spain
Prior art keywords
fragments
antibodies against
procedure
polypeptides
against aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8801342A
Other languages
English (en)
Inventor
Wilhem Bannwarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2010538A6 publication Critical patent/ES2010538A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN GEN SINTETICO, QUE CODIFICA UN POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDO REPRESENTADA POR LA FORMULA (I) O SUS FRAGMENTOS QUE PRODUCEN ANTICUERPOS FRENTE A VIRUS SIDA Y/O QUE REACCIONAN CON SIDA-ANTICUERPOS. EL PROCEDIMIENTO CONSISTE EN SINTETIZAR FRAGMENTOS OLIGONUCLEOTIDOS CON PROCEDIMIENTOS CONVENCIONALES DE SINTESIS DE OLIGONUCLEOTIDOS, E HIBRIDIZAR Y LIGAR DICHOS FRAGMENTOS EN ETAPAS PREDETERMINADAS PARA DAR LA SECUENCIA NUCLEOTIDA DOBLE FILAMENTADA COMPLETA DE DICHO GEN SINTETICO. EL PROCEDIMIENTO PERMITE TAMBIEN FUNDIR LA SECUENCIA ANTERIOR O UNA SEGUNDA SECUENCIA NUCLEOTIDA DOBLE FILAMENTADA QUE CODIFICA UNA PROTEINA PROCARIOTICA O ENCARIOTICA FORMANDOSE EL CORRESPONDIENTE GEN SINTETICO.
ES8801342A 1985-10-17 1988-04-29 Procedimiento para la preparacion de un gen sintetico. Expired ES2010538A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525615A GB8525615D0 (en) 1985-10-17 1985-10-17 Polypeptides

Publications (1)

Publication Number Publication Date
ES2010538A6 true ES2010538A6 (es) 1989-11-16

Family

ID=10586812

Family Applications (7)

Application Number Title Priority Date Filing Date
ES8602630A Expired ES2009210A6 (es) 1985-10-17 1986-10-16 Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ES8801337A Expired ES2009905A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de anticuerpos frente a virus de sida.
ES8801341A Expired - Lifetime ES2014527A6 (es) 1985-10-17 1988-04-29 Procedimiento para la determinacion de virus sida.
ES8801342A Expired ES2010538A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de un gen sintetico.
ES8801339A Expired ES2009907A6 (es) 1985-10-17 1988-04-29 Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
ES8801338A Expired ES2009906A6 (es) 1985-10-17 1988-04-29 Procedimiento de preparacion de transformantes bacterianos.
ES8801340A Expired ES2006925A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de vectores de expresion.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES8602630A Expired ES2009210A6 (es) 1985-10-17 1986-10-16 Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ES8801337A Expired ES2009905A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de anticuerpos frente a virus de sida.
ES8801341A Expired - Lifetime ES2014527A6 (es) 1985-10-17 1988-04-29 Procedimiento para la determinacion de virus sida.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES8801339A Expired ES2009907A6 (es) 1985-10-17 1988-04-29 Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
ES8801338A Expired ES2009906A6 (es) 1985-10-17 1988-04-29 Procedimiento de preparacion de transformantes bacterianos.
ES8801340A Expired ES2006925A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de vectores de expresion.

Country Status (11)

Country Link
EP (1) EP0219106A3 (es)
JP (1) JPS6299398A (es)
AU (1) AU602315B2 (es)
BR (1) BR8605053A (es)
DK (1) DK496486A (es)
ES (7) ES2009210A6 (es)
GB (1) GB8525615D0 (es)
IL (1) IL80304A0 (es)
NO (1) NO864139L (es)
NZ (1) NZ217895A (es)
ZA (1) ZA867748B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6218102B1 (en) * 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
SE8802176D0 (sv) * 1988-06-10 1988-06-10 Kabigen Ab Fusion protein and its use
EP0396653A1 (en) * 1988-08-30 1990-11-14 Applied Research Systems ARS Holding N.V. Recombinant fusion proteins for altering hormone secretion
EP0361749B1 (en) * 1988-09-27 1995-02-08 Dana Farber Cancer Institute A vector comprising a replication competent HIV-I provirus and a heterologous gene
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
IT1271486B (it) * 1993-10-12 1997-05-28 Italfarmaco Spa Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
WO1999045395A1 (en) * 1998-03-04 1999-09-10 Universal Healthwatch, Inc. Rapid confirmatory test for microbial infections
DE60336978D1 (de) * 2003-04-11 2011-06-16 Pasteur Institut Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper
CA2567813C (en) 2004-05-23 2015-11-24 Gerard M. Housey Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
EP1279678B1 (en) * 1984-10-18 2007-09-12 Institut Pasteur Gag antigen and its use for the detection of lav infection and in immunogenic compositions
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
ATE116006T1 (de) * 1985-04-29 1995-01-15 Genetic Systems Corp Synthetische antigene zum nachweis von aids.

Also Published As

Publication number Publication date
AU602315B2 (en) 1990-10-11
IL80304A0 (en) 1987-01-30
GB8525615D0 (en) 1985-11-20
DK496486D0 (da) 1986-10-16
NZ217895A (en) 1991-05-28
ES2006925A6 (es) 1989-05-16
ZA867748B (en) 1987-07-29
DK496486A (da) 1987-04-18
EP0219106A2 (en) 1987-04-22
AU6399786A (en) 1987-04-30
ES2009906A6 (es) 1989-10-16
ES2009905A6 (es) 1989-10-16
NO864139L (no) 1987-04-21
ES2009907A6 (es) 1989-10-16
ES2014527A6 (es) 1990-07-16
ES2009210A6 (es) 1989-09-16
EP0219106A3 (en) 1989-02-08
BR8605053A (pt) 1987-07-14
NO864139D0 (no) 1986-10-16
JPS6299398A (ja) 1987-05-08

Similar Documents

Publication Publication Date Title
ES2010538A6 (es) Procedimiento para la preparacion de un gen sintetico.
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
PT87562A (pt) Procede de expression de la proapolipoproteine a-i humaine
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
CY1108212T1 (el) Αντιγονα συγγενη με το α-33 και οι φαρμακολογικες τους χρησεις
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES8705467A1 (es) Un procedimiento para producir la proteina apoacuorina
ES8705521A1 (es) Un metodo de producir un polipetido similar a factor de necrosis de tumores (tnf) de mamiferos.
CO5590973A2 (es) Acido nucleico de adenovirus de simio y secuiencias de aminoacidos, vectores que contienen los mismos y metodos de uso
CY1110679T1 (el) Νουκλεοτιδικες και πρωτεϊνικες ακολουθιες γονιδιων nogo και μεθοδοι βασιζομενες σε αυτες
AU1342888A (en) Molecules comprising at least one peptidic sequence carrying one or a plurality of epitopes characterizing a protein produced by P.Falciparum in hepatocytes and compositions containing them
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
KR840009069A (ko) 향정신성 펩티드류의 제조 방법
ES2059330T3 (es) Un cdna codificador de antigeno carcinoembrionico.
EP0546087A4 (es)
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
PT635025E (pt) Processo para preparar proteinas modificadas
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
GB8906156D0 (en) Production and use of anthelmintic agents and protective immunogens
ES2090365T3 (es) Un procedimiento para la produccion de proteinas hidrolizadas.
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009